Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Vir Biotechnology Reports $1.7B In Cash, Cash Equivalents And Investments In Q3; Expects To Reduce Its Cost Structure By At Least $40M Annually

Author: Benzinga Newsdesk | December 13, 2023 05:11pm

Posted In: VIR